China SXT Stock Forward View - Simple Regression
| SXTC Stock | USD 2.82 1.12 28.43% |
China Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast China SXT stock prices and determine the direction of China SXT Pharmaceuticals's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of China SXT's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the relative strength index (rsi) of China SXT's share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Quarterly Earnings Growth 0.426 | Quarterly Revenue Growth (0.24) |
Using China SXT hype-based prediction, you can estimate the value of China SXT Pharmaceuticals from the perspective of China SXT response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of China SXT Pharmaceuticals on the next trading day is expected to be 23.61 with a mean absolute deviation of 55.97 and the sum of the absolute errors of 3,470. China SXT after-hype prediction price | USD 2.24 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of China SXT to cross-verify your projections. China SXT Additional Predictive Modules
Most predictive techniques to examine China price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for China using various technical indicators. When you analyze China charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
China SXT Simple Regression Price Forecast For the 7th of February
Given 90 days horizon, the Simple Regression forecasted value of China SXT Pharmaceuticals on the next trading day is expected to be 23.61 with a mean absolute deviation of 55.97, mean absolute percentage error of 4,448, and the sum of the absolute errors of 3,470.Please note that although there have been many attempts to predict China Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that China SXT's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
China SXT Stock Forecast Pattern
| Backtest China SXT | China SXT Price Prediction | Research Analysis |
China SXT Forecasted Value
In the context of forecasting China SXT's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. China SXT's downside and upside margins for the forecasting period are 6.05 and 41.18, respectively. We have considered China SXT's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of China SXT stock data series using in forecasting. Note that when a statistical model is used to represent China SXT stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 128.3487 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 55.975 |
| MAPE | Mean absolute percentage error | 2.0013 |
| SAE | Sum of the absolute errors | 3470.448 |
Predictive Modules for China SXT
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as China SXT Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of China SXT's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
China SXT After-Hype Price Density Analysis
As far as predicting the price of China SXT at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in China SXT or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of China SXT, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
China SXT Estimiated After-Hype Price Volatility
In the context of predicting China SXT's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on China SXT's historical news coverage. China SXT's after-hype downside and upside margins for the prediction period are 0.11 and 19.91, respectively. We have considered China SXT's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
China SXT is abnormally volatile at this time. Analysis and calculation of next after-hype price of China SXT Pharmaceuticals is based on 3 months time horizon.
China SXT Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as China SXT is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading China SXT backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with China SXT, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
4.05 | 17.56 | 6.07 | 0.05 | 8 Events / Month | 5 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.82 | 2.24 | 20.53 |
|
China SXT Hype Timeline
China SXT Pharmaceuticals is at this time traded for 2.82. The entity has historical hype elasticity of -6.07, and average elasticity to hype of competition of -0.05. China is anticipated to decline in value after the next headline, with the price expected to drop to 2.24. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -20.53%, whereas the daily expected return is at this time at -4.05%. The volatility of related hype on China SXT is about 158040.0%, with the expected price after the next announcement by competition of 2.77. About 29.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.17. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. China SXT Pharmaceuticals recorded a loss per share of 57.15. The entity had not issued any dividends in recent years. The firm had 1:150 split on the 3rd of February 2026. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days. Check out Historical Fundamental Analysis of China SXT to cross-verify your projections.China SXT Related Hype Analysis
Having access to credible news sources related to China SXT's direct competition is more important than ever and may enhance your ability to predict China SXT's future price movements. Getting to know how China SXT's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how China SXT may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ATLN | Atlantic International Corp | 0.04 | 9 per month | 7.15 | 0.08 | 20.00 | (13.66) | 64.87 | |
| IXHL | Incannex Healthcare Ltd | (0.01) | 9 per month | 0.00 | (0.11) | 10.00 | (7.50) | 23.38 | |
| CYBN | Cybin Inc | (0.15) | 9 per month | 0.00 | (0.04) | 6.03 | (7.30) | 16.13 | |
| AVR | Anteris Technologies Global | (0.13) | 7 per month | 3.44 | 0.06 | 9.42 | (5.99) | 25.09 | |
| SAVA | Cassava Sciences | (0.12) | 7 per month | 0.00 | (0.13) | 9.05 | (7.56) | 35.02 | |
| FATE | Fate Therapeutics | 0.02 | 8 per month | 0.00 | (0.07) | 7.27 | (7.63) | 20.97 | |
| IPHA | Innate Pharma | (0.03) | 7 per month | 0.00 | (0.03) | 3.41 | (3.87) | 39.49 | |
| MIST | Milestone Pharmaceuticals | 0.04 | 8 per month | 0.00 | (0.02) | 6.15 | (6.38) | 34.31 | |
| NVCT | Nuvectis Pharma | 0.24 | 8 per month | 2.93 | 0.1 | 7.20 | (4.81) | 17.53 |
Other Forecasting Options for China SXT
For every potential investor in China, whether a beginner or expert, China SXT's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. China Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in China. Basic forecasting techniques help filter out the noise by identifying China SXT's price trends.China SXT Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with China SXT stock to make a market-neutral strategy. Peer analysis of China SXT could also be used in its relative valuation, which is a method of valuing China SXT by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
China SXT Market Strength Events
Market strength indicators help investors to evaluate how China SXT stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading China SXT shares will generate the highest return on investment. By undertsting and applying China SXT stock market strength indicators, traders can identify China SXT Pharmaceuticals entry and exit signals to maximize returns.
| Accumulation Distribution | 135482.0 | |||
| Daily Balance Of Power | (1.01) | |||
| Rate Of Daily Change | 0.72 | |||
| Day Median Price | 3.19 | |||
| Day Typical Price | 3.06 | |||
| Price Action Indicator | (0.93) | |||
| Period Momentum Indicator | (1.12) |
China SXT Risk Indicators
The analysis of China SXT's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in China SXT's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting china stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 10.04 | |||
| Standard Deviation | 17.02 | |||
| Variance | 289.52 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for China SXT
The number of cover stories for China SXT depends on current market conditions and China SXT's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that China SXT is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about China SXT's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
China SXT Short Properties
China SXT's future price predictability will typically decrease when China SXT's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of China SXT Pharmaceuticals often depends not only on the future outlook of the potential China SXT's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. China SXT's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 403.9 K | |
| Cash And Short Term Investments | 18.1 M |
Check out Historical Fundamental Analysis of China SXT to cross-verify your projections. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Will Personal Care Products sector continue expanding? Could China diversify its offerings? Factors like these will boost the valuation of China SXT. If investors know China will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every China SXT data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.426 | Earnings Share (57.15) | Revenue Per Share | Quarterly Revenue Growth (0.24) | Return On Assets |
The market value of China SXT Pharmaceuticals is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China SXT's value that differs from its market value or its book value, called intrinsic value, which is China SXT's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because China SXT's market value can be influenced by many factors that don't directly affect China SXT's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China SXT's value and its price as these two are different measures arrived at by different means. Investors typically determine if China SXT is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, China SXT's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.